Loading...
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
BACKGROUND: Knowledge about tumour gene mutation status is essential for the treatment of increasing numbers of cancer patients, and testing quality has a major impact on treatment response and cost. In 2012, 4,629 tests for BRAF p.V600 were performed in France, in patients with melanomas. METHODS:...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3852250/ https://ncbi.nlm.nih.gov/pubmed/24119386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-472 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|